Now accepting next day appointments
This is a study to evaluate if there is a difference in bone mineral density in adolescents who are taking our FDA approved hormonal contraceptives, compared to adolescents who are not taking hormonal contraceptives. We are enrolling 14 -17 year old female adolescents.
Participants will be allowed to choose which one of our FDA approved contraceptive methods they would like to use for the duration of the clinical trial. Or participants can choose no contraception.
If the participant decides to use a hormonal contraceptive, she will be able to choose between our oral contraceptive, or our chewable contraceptive. Both options are progestin-only, and their active ingredient is Drospirenone.
To be included in the study:
- Must be generally healthy
- Do not need to be sexually active (regardless of choosing birth control option or not)
- Must have regular menstrual cycles for at least 2 years
The aim of this phase 4, outpatient clinical trial is to study the differences in bone mineral density in women who are taking one of our FDA approved hormonal contraceptives, compared to women who are not using hormonal contraceptives.
During this trial, participants will receive non-invasive DXA (Bone Density) scans. This is a painless procedure, where X-rays are used to measure the bone mineral density.
We are looking for 14- to 17-year-old females to participate in this 12-month trial.